Terms: = Pancreatic cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Diagnosis
14 results:
1. Age-specific cardiovascular disease-related mortality among patients with major gastrointestinal cancers: A SEER population-based study.
Liu G; Zhang BF
Cancer Med; 2023 Aug; 12(16):17253-17265. PubMed ID: 37387603
[TBL] [Abstract] [Full Text] [Related]
2. [Exocrine pancreatic cancer - what is new in the update of the S3 guideline?].
Seufferlein T; Kestler A
Dtsch Med Wochenschr; 2023 Jun; 148(12):737-743. PubMed ID: 37257475
[TBL] [Abstract] [Full Text] [Related]
3. Role of N
Ye T; Wang J; Zhao H; Zhao G; Li P
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36367195
[TBL] [Abstract] [Full Text] [Related]
4. The role of cytology in the investigation and management of pancreatobiliary lesions with a transition towards a standardised reporting system: An institutional perspective.
Hanks M; Ryder S; Zaitoun A
Cytopathology; 2022 May; 33(3):293-300. PubMed ID: 35231151
[TBL] [Abstract] [Full Text] [Related]
5. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.
COVIDSurg Collaborative
Lancet Oncol; 2021 Nov; 22(11):1507-1517. PubMed ID: 34624250
[TBL] [Abstract] [Full Text] [Related]
6. Early Palliative Care Is Associated With Reduced Emergency Department Utilization in pancreatic cancer.
Bevins J; Bhulani N; Goksu SY; Sanford NN; Gao A; Ahn C; Paulk ME; Terauchi S; Pruitt SL; Tavakkoli A; Rhodes RL; Kazmi SMA; Beg MS
Am J Clin Oncol; 2021 May; 44(5):181-186. PubMed ID: 33710133
[TBL] [Abstract] [Full Text] [Related]
7. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study.
Kim JS; Kang EJ; Kim DS; Choi YJ; Lee SY; Kim HJ; Seo HY; Kim JS
BMC Cancer; 2018 Dec; 18(1):1260. PubMed ID: 30558603
[TBL] [Abstract] [Full Text] [Related]
8. New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm.
Shimizu Y; Hijioka S; Hirono S; Kin T; Ohtsuka T; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Matsuo K; Yanagisawa A; Yamaue H; Sugiyama M; Okazaki K
Ann Surg; 2020 Jul; 272(1):155-162. PubMed ID: 30499803
[TBL] [Abstract] [Full Text] [Related]
9. The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.
Stemann Lau T; Dam G; Jepsen P; Grønbæk H; Krogh K; Gregersen T
Neuroendocrinology; 2018; 107(3):280-283. PubMed ID: 30092588
[TBL] [Abstract] [Full Text] [Related]
10. pancreatic Resection for Side-Branch Intraductal Papillary Mucinous Neoplasm (SB-IPMN): a Contemporary Single-Institution Experience.
Dortch JD; Stauffer JA; Asbun HJ
J Gastrointest Surg; 2015 Sep; 19(9):1603-9. PubMed ID: 26055134
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
Stotz M; Szkandera J; Seidel J; Stojakovic T; Samonigg H; Reitz D; Gary T; Kornprat P; Schaberl-Moser R; Hoefler G; Gerger A; Pichler M
PLoS One; 2014; 9(8):e104730. PubMed ID: 25133546
[TBL] [Abstract] [Full Text] [Related]
12. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into cancer and Nutrition (EPIC) cohort.
Grote VA; Rohrmann S; Nieters A; Dossus L; Tjønneland A; Halkjær J; Overvad K; Fagherazzi G; Boutron-Ruault MC; Morois S; Teucher B; Becker S; Sluik D; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Vineis P; Panico S; Rodríguez L; Duell EJ; Molina-Montes E; Dorronsoro M; Huerta JM; Ardanaz E; Jeurnink SM; Beulens JW; Peeters PH; Sund M; Ye W; Lindkvist B; Johansen D; Khaw KT; Wareham N; Allen N; Crowe F; Jenab M; Romieu I; Michaud DS; Riboli E; Romaguera D; Bueno-de-Mesquita HB; Kaaks R
Diabetologia; 2011 Dec; 54(12):3037-46. PubMed ID: 21953276
[TBL] [Abstract] [Full Text] [Related]
13. pancreatic cancer genetic epidemiology consortium.
Petersen GM; de Andrade M; Goggins M; Hruban RH; Bondy M; Korczak JF; Gallinger S; Lynch HT; Syngal S; Rabe KG; Seminara D; Klein AP
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):704-10. PubMed ID: 16614112
[TBL] [Abstract] [Full Text] [Related]
14. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
[TBL] [Abstract] [Full Text] [Related]
